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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A319Conclusions: The results of this study suggest that HDMPs might be a
common feature in ageing and degenerating weight bearing joints. The
existence of these structures provides novel insights into the mecha-
nism of joint destruction, highlighting the central role of micro-
anatomical changes to the subchondral plate. HDMPs provide a novel
imaging biomarker of joint destruction for diagnosis of joint disease and
to monitor disease progression.
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CHANGES IN EPIPHYSEAL BONE, SUBCHONDRAL BONE PLATE AND
EPIPHYSEAL TRABECULAR BONE IN SURGICALLY AND CHEMICALLY
INDUCED RAT MODELS OF OSTEOARTHRITIS
J. Morko, Z. Peng, J. V€a€ar€aniemi, K.M. Fagerlund, J.P. Rissanen,
J. Bernoulli, J.M. Halleen. Pharmatest Services Ltd, Turku, Finland
Purpose: Several experimental animal models have been developed for
human osteoarthritis (OA) and used to study the preclinical efﬁcacy of
disease and symptom modifying OA drug candidates. The preclinical
efﬁcacy has been determined by various microscopic scoring systems
and joint pain assessments. The histopathology initiative of Osteo-
arthritis Research Society International (OARSI) has presented recom-
mendations for OA assessment in order to standardize preclinical
efﬁcacy studies. Recommendations for rat samples include the histo-
logical analysis of cartilage degeneration and extracellular matrix (ECM)
loss, osteophytes, calciﬁed cartilage and subchondral bone, synovium,
joint capsule, and growth plate. As subchondral bone has been identi-
ﬁed to play an important role in the development and progression of
OA, treatment effects on bone tissue have been studied even in more
detailed. In this study, we performed a systemic characterization of
epiphyseal bone, subchondral bone plate and epiphyseal trabecular
bone together with the assessment of knee joint discomfort and pain
and degenerative changes in articular cartilage and synovium in four rat
OA models.
Methods: The study was conducted using male Lewis rats (body weight
range 330-380 g). Unilateral OA was induced in their knee joints by
applying the following models: 1) intra-articular injection of mono-
iodoacetate (MIA) at the dose of 1 mg, 2) medial meniscal tear (MMT)
combined with medial collateral ligament transection (MCLT), 3)
anterior cruciate ligament transection (ACLT) combined with partial
medial meniscectomy (pMMx), 4) ACLT. Body weight and OA symptoms
were followed in each model during the study. Knee joint discomfort
and pain were used as the symptoms of OA. Knee joint discomfort was
analyzed as static weight bearing using Incapacitance Tester and knee
joint pain as static mechanical allodynia using von Frey monoﬁlaments.
Knee joints were harvested at two different time points in each model
as follows: in the MIA model at 2 and 4 weeks, in the MMT þ MCLT
model at 3 and 6 weeks, in the ACLT þ pMMx model at 4 and 8 weeks,
and in the ACLT model at 5 and 10 weeks. The structure of epiphyseal
bone, subchondral bone plate and epiphyseal trabecular bone were
analyzed in coronal sections of medial tibial plateau followed by the
histological OA assessment as recommended by the OARSI histo-
pathology initiative. This experimental protocol was approved by
National Animal Experiment Board, Regional State Administrative
Agency for Southern Finland, H€ameenlinna, Finland.
Results: Knee joint discomfort was observed in operated hind limbs as
decreased static weight bearing during the ﬁrst week of the study. Knee
joint pain was identiﬁed in operated and MIA-injected hind limbs as
decreased paw withdrawal threshold during the ﬁrst week and at the
end of in-life phase of each model. In the rat MIA model, this knee joint
pain was associated with mild synovial inﬂammation at 2 weeks, car-
tilage degeneration and ECM loss in superﬁcial layer at 2 weeks and
exacerbating down to intermediate layer at 4 weeks, and with the
reduction in the amount of epiphyseal and subchondral bone. In the rat
MMT þ MCLT model, the knee joint pain was observed together with
synovial inﬂammation, cartilage degeneration and the loss of ECM from
superﬁcial layer down to tidemark at 3 and 6 weeks, large osteophytes,
and with the increased amount of epiphyseal and subchondral bone. In
the rat ACLT þ pMMx model, the pain of knee joint was identiﬁed in
association with synovial inﬂammation, cartilage degeneration and
ECM loss from superﬁcial layer down to tidemark at 4 and 8 weeks, and
with large osteophytes. In the rat ACLT model, the knee joint pain was
associated with mild synovial inﬂammation, cartilage degeneration and
the loss of ECM in superﬁcial layer at 5 weeks and exacerbating down to
deep layer at 10 weeks, osteophytes, and with the reduction in the
amount of subchondral bone.Conclusions: This study characterized changes in the structure of epi-
physeal bone, subchondral bone plate and epiphyseal trabecular bone
together with degenerative changes in articular cartilage and synovium,
and knee joint discomfort and pain in four rat OA models. The amount
of bone decreased in the rat OA models exhibiting from mild to mod-
erate degenerative changes in articular cartilage, whereas the amount
of bone remained unchanged or increased in the rat OA models
exhibiting from moderate to severe degenerative cartilage changes.
These results can be used to design studies for testing the preclinical
treatment effects of OA drug candidates on articular cartilage, syno-
vium, epiphyseal bone, and knee joint discomfort and pain.
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COMMON GENES BETWEEN HUMAN AND RODENT OSTEOARTHRITIS
CARTILAGE STUDIES SHOW LITTLE OVERLAP WITH AN
INFLAMMATORY GENE-SET
A. Chanalaris. Univ. of Oxford, Oxford, United Kingdom
Purpose: We were interested to compare published gene sets of
microarray studies on cartilage samples from rodent models of surgi-
cally induced, chemically induced and spontaneous osteoarthritis (OA).
We also compare the datasets to published gene sets from human
osteoarthritic cartilage, in order to determine genes that are dysregu-
lated in osteoarthritis regardless of species and models used.
Furthermore wewere interested to identify which of those genes might
be related with infammation.
Methods: We used gene sets that adhered to the following criteria:
1) Was from pure cartilage or from samples enriched for cartilage
2) The species of origin was mouse, rat or human
3) We only preferred studies that have been deposited in a public
database
4) We compared the datasets to a gene-set that was bioinformatically
constructed to consider genes that are involved on the onset, resolution
and response to inﬂammation. The study was gene centric, rather than
probe centric and the genes mapping to the probes for each microarray
was used for annotation purposes. For comparison of the different
species, all genes were converted to the mouse ENTREZ gene ids. The
common data sets were examined for gene ontology term enrichment
and KEGG pathway enrichment.
Results: A high degree of overlap between the surgically and chemically
induced OA models in rodents was observed. KEGG pathway analysis
reveals that TGF beta pathway is the only pathway that is not over-
represented in the chemically induced array.
In total we identify 75 genes that are common in more than 50% of the
arrays. In this group of 75 genes only 7 appear to be present in the
inﬂammatory gene-set (p>0.05). However, if single arrays are examined
the probability mass function of the overlap with the inﬂammatory
gene-set is always less than 0.05 and for some arrays as low as 6.2 x 10-
14. At the 4 weeks time point the probability mass function increased.
10 genes are present in more than 8 out of the 11 OA datasets studied
with no inﬂammatory counterpart.
Conclusions: The cartilage response that leads to OA appears to follow a
common transcriptional trajectory regardless of the insult that has
caused it. Although inﬂammatory molecules produced by the cartilage
are part of the OA response, a signiﬁcant part of the transcriptional
cartilage response appears to be independent to inﬂammation.
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MCP-1-CCR2 LIGAND-RECEPTOR AXIS IN HUMAN CHONDROCYTE
DEGRADATION AND DISEASE PROGRESS IN OSTEOARTHRITIS
X. Yuankun, Sr.. Peking Univ., Beijing, China
Purpose: To investigate the role of (OA).
Methods: Expression of the C-C chemokines monocyte chemo-
attractant protein 1 (MCP-1), and it's receptor CCR-2, was assessed in 16
OA patients and 6 normal controls, by reverse transcriptase-polymerase
chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA)
on MCP-1 stimulated chondrocytes, and the apoptosis of the chon-
drocytes was detected by ﬂow cytometry. While, the Expression of the
markers, collagen I, V, IX, XI and Matrix metalloproteinases (MMP), of
chondrocyte degenerationwas assessed by ELISA. Finally, as to estimate
the essentiality of MCP-1-CCR2 ligand-receptor axis in induce and
maintain the pathologic features of OA, the CCR-2 antagonist
(RS102895) was used to block the animal model of OA in rats induced by
